Technology ID
TAB-4564

Neuronal Differentiation of Neural Stem Cells with StemPro Embryonic Stem Cell Serum Free Medium for Research and Therapeutic Development

E-Numbers
E-608-2013-0
Lead Inventor
Malik, Nasir (National Institutes of Health (NIH) Center for Neuroscience and Regenerative Med)
Co-Inventors
Rao, Mahendra (National Institutes of Health (NIH) Center for Neuroscience and Regenerative Med)
Applications
Research Materials
Therapeutic Areas
Neurology
Development Stages
Pre-Clinical (in vitro)
Research Products
Human iPSC Lines
Lead IC
NIAMS

This technology involves an innovative method for differentiating neural stem cells (NSCs) into neurons, primarily for use in basic science research and in developing therapies for brain and spinal cord disorders. Existing methods for generating neurons from NSCs typically result in high efficiency but low survival rates, especially when neurons are dissociated and regrown. This new method utilizes Life Technologies StemPro embryonic stem cell serum-free medium, which significantly enhances differentiation efficiency into neurons with minimal cell death. A notable aspect of this technology is the high viability of neurons even after being frozen, thawed, and regrown. The technology stands out from previous neuronal differentiation protocols by enabling efficient neuron derivation with high viability, both at the time of generation and after being stored as frozen cells. This advancement has the potential to significantly aid in understanding neuronal development mechanisms and could be instrumental in large-scale neuron generation for clinical applications in cellular replacement therapies targeting the brain and spinal cord.

Commercial Applications
This technology has potential applications in advancing basic research on neuronal development and in facilitating large-scale generation of viable neurons for cellular replacement therapies in treating brain and spinal cord disorders.

Competitive Advantages
The discovery can efficiently differentiate neural stem cells into highly viable neurons, which can be frozen, stored, and later regrown with minimal cell death, a significant improvement over existing neuronal differentiation methods.

Request More Info

Licensing Contact:
Knezevic, Vladimir
vlado.knezevic@nih.gov

Collaborations

  • Licensing

Collaboration Description

  • We are seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology.
Date Published